Annual Operating Profit
-$91.69 M
+$19.78 M+17.74%
December 31, 2023
Summary
- As of February 7, 2025, AUPH annual operating income is -$91.69 million, with the most recent change of +$19.78 million (+17.74%) on December 31, 2023.
- During the last 3 years, AUPH annual operating profit has risen by +$12.60 million (+12.08%).
- AUPH annual operating profit is now -7006.18% below its all-time high of -$1.29 million, reached on November 30, 1999.
Performance
AUPH Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
$11.75 M
+$12.19 M+2763.95%
September 30, 2024
Summary
- As of February 7, 2025, AUPH quarterly operating income is $11.75 million, with the most recent change of +$12.19 million (+2763.95%) on September 30, 2024.
- Over the past year, AUPH quarterly operating profit has increased by +$12.19 million (+2763.95%).
- AUPH quarterly operating profit is now at all-time high.
Performance
AUPH Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$24.94 M
+$28.01 M+52.90%
September 30, 2024
Summary
- As of February 7, 2025, AUPH TTM operating income is -$24.94 million, with the most recent change of +$28.01 million (+52.90%) on September 30, 2024.
- Over the past year, AUPH TTM operating profit has increased by +$28.01 million (+52.90%).
- AUPH TTM operating profit is now -1599.52% below its all-time high of $1.66 million, reached on September 30, 2002.
Performance
AUPH TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
AUPH Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +17.7% | +2763.9% | +52.9% |
| 3 y3 years | +12.1% | +223.7% | +78.5% |
| 5 y5 years | -64.0% | +223.7% | +78.5% |
AUPH Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +49.3% | at high | +131.0% | at high | +86.2% |
| 5 y | 5-year | -0.8% | +49.3% | at high | +123.2% | at high | +86.2% |
| alltime | all time | -7006.2% | +49.3% | at high | +123.2% | -1599.5% | +86.2% |
Aurinia Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $11.75 M(-2763.9%) | -$24.94 M(-52.9%) |
| Jun 2024 | - | -$441.00 K(-93.3%) | -$52.95 M(-22.9%) |
| Mar 2024 | - | -$6.57 M(-77.9%) | -$68.68 M(-25.1%) |
| Dec 2023 | -$91.69 M(-17.7%) | -$29.67 M(+82.5%) | -$91.69 M(+1.7%) |
| Sep 2023 | - | -$16.26 M(+0.6%) | -$90.12 M(+8.1%) |
| Jun 2023 | - | -$16.17 M(-45.3%) | -$83.35 M(-19.2%) |
| Mar 2023 | - | -$29.58 M(+5.3%) | -$103.17 M(-7.4%) |
| Dec 2022 | -$111.47 M(-38.3%) | -$28.10 M(+195.8%) | -$111.47 M(-4.0%) |
| Sep 2022 | - | -$9.50 M(-73.6%) | -$116.08 M(-26.0%) |
| Jun 2022 | - | -$35.99 M(-5.0%) | -$156.93 M(-6.6%) |
| Mar 2022 | - | -$37.88 M(+15.8%) | -$168.07 M(-7.0%) |
| Dec 2021 | -$180.74 M(+73.3%) | -$32.70 M(-35.0%) | -$180.74 M(+15.8%) |
| Sep 2021 | - | -$50.35 M(+6.8%) | -$156.08 M(+5.4%) |
| Jun 2021 | - | -$47.13 M(-6.7%) | -$148.04 M(+15.9%) |
| Mar 2021 | - | -$50.54 M(+527.7%) | -$127.77 M(+24.8%) |
| Dec 2020 | -$104.29 M(+14.7%) | -$8.05 M(-81.0%) | -$102.37 M(-21.2%) |
| Sep 2020 | - | -$42.31 M(+57.5%) | -$129.91 M(+16.4%) |
| Jun 2020 | - | -$26.86 M(+6.8%) | -$111.61 M(+10.3%) |
| Mar 2020 | - | -$25.14 M(-29.4%) | -$101.20 M(+11.3%) |
| Dec 2019 | -$90.94 M(+62.7%) | -$35.59 M(+48.2%) | -$90.94 M(+30.4%) |
| Sep 2019 | - | -$24.01 M(+45.9%) | -$69.76 M(+16.5%) |
| Jun 2019 | - | -$16.45 M(+10.5%) | -$59.86 M(+3.7%) |
| Mar 2019 | - | -$14.88 M(+3.3%) | -$57.74 M(+3.3%) |
| Dec 2018 | -$55.91 M(+18.8%) | -$14.41 M(+2.1%) | -$55.91 M(+4.2%) |
| Sep 2018 | - | -$14.11 M(-1.6%) | -$53.63 M(+0.6%) |
| Jun 2018 | - | -$14.34 M(+9.9%) | -$53.32 M(+8.8%) |
| Mar 2018 | - | -$13.05 M(+7.5%) | -$49.03 M(+4.2%) |
| Dec 2017 | -$47.06 M(+106.3%) | -$12.14 M(-12.0%) | -$47.06 M(+9.6%) |
| Sep 2017 | - | -$13.79 M(+37.2%) | -$42.95 M(+24.3%) |
| Jun 2017 | - | -$10.05 M(-9.3%) | -$34.55 M(+18.9%) |
| Mar 2017 | - | -$11.09 M(+38.1%) | -$29.05 M(+27.3%) |
| Dec 2016 | -$22.81 M(-3.2%) | -$8.03 M(+48.9%) | -$22.81 M(+12.3%) |
| Sep 2016 | - | -$5.39 M(+18.4%) | -$20.31 M(-4.9%) |
| Jun 2016 | - | -$4.55 M(-6.1%) | -$21.35 M(-6.6%) |
| Mar 2016 | - | -$4.85 M(-12.3%) | -$22.85 M(-3.1%) |
| Dec 2015 | -$23.58 M(+36.4%) | -$5.52 M(-14.1%) | -$23.58 M(+3.0%) |
| Sep 2015 | - | -$6.43 M(+6.2%) | -$22.90 M(+11.0%) |
| Jun 2015 | - | -$6.05 M(+8.5%) | -$20.62 M(+7.8%) |
| Mar 2015 | - | -$5.58 M(+15.2%) | -$19.14 M(+10.7%) |
| Dec 2014 | -$17.28 M(+316.0%) | -$4.84 M(+16.7%) | -$17.28 M(+24.9%) |
| Sep 2014 | - | -$4.15 M(-9.2%) | -$13.83 M(+29.4%) |
| Jun 2014 | - | -$4.57 M(+22.7%) | -$10.69 M(+51.6%) |
| Mar 2014 | - | -$3.72 M(+167.6%) | -$7.05 M(+69.8%) |
| Dec 2013 | -$4.15 M(-24.0%) | -$1.39 M(+37.6%) | -$4.15 M(-50.6%) |
| Sep 2013 | - | -$1.01 M(+8.9%) | -$8.41 M(-7.5%) |
| Jun 2013 | - | -$928.00 K(+12.6%) | -$9.09 M(-9.8%) |
| Mar 2013 | - | -$824.00 K(-85.4%) | -$10.07 M(+84.6%) |
| Dec 2012 | -$5.47 M(-13.3%) | -$5.64 M(+233.8%) | -$5.46 M(+224.0%) |
| Sep 2012 | - | -$1.69 M(-11.5%) | -$1.68 M(+52.9%) |
| Jun 2012 | - | -$1.91 M(-150.4%) | -$1.10 M(+0.4%) |
| Mar 2012 | - | $3.79 M(-302.4%) | -$1.10 M(-83.6%) |
| Dec 2011 | -$6.30 M | -$1.87 M(+68.9%) | -$6.68 M(-6.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2011 | - | -$1.11 M(-41.9%) | -$7.10 M(-4.0%) |
| Jun 2011 | - | -$1.91 M(+6.3%) | -$7.40 M(+21.4%) |
| Mar 2011 | - | -$1.79 M(-21.9%) | -$6.09 M(+16.3%) |
| Dec 2010 | -$5.24 M(-47.3%) | -$2.30 M(+63.8%) | -$5.24 M(+7.5%) |
| Sep 2010 | - | -$1.40 M(+132.6%) | -$4.87 M(-10.2%) |
| Jun 2010 | - | -$602.40 K(-35.9%) | -$5.43 M(-26.2%) |
| Mar 2010 | - | -$939.80 K(-51.3%) | -$7.36 M(-20.2%) |
| Dec 2009 | -$9.95 M(-36.3%) | -$1.93 M(-1.2%) | -$9.22 M(+5.5%) |
| Sep 2009 | - | -$1.95 M(-22.9%) | -$8.74 M(-17.2%) |
| Jun 2009 | - | -$2.53 M(-9.6%) | -$10.55 M(-22.4%) |
| Mar 2009 | - | -$2.80 M(+93.3%) | -$13.59 M(-14.9%) |
| Dec 2008 | -$15.62 M(-56.5%) | -$1.45 M(-61.5%) | -$15.97 M(-32.1%) |
| Sep 2008 | - | -$3.77 M(-32.4%) | -$23.51 M(-15.7%) |
| Jun 2008 | - | -$5.57 M(+7.4%) | -$27.90 M(-13.1%) |
| Mar 2008 | - | -$5.19 M(-42.3%) | -$32.09 M(-5.6%) |
| Dec 2007 | -$35.88 M(+48.6%) | -$8.98 M(+10.1%) | -$33.98 M(+9.2%) |
| Sep 2007 | - | -$8.16 M(-16.5%) | -$31.11 M(+5.0%) |
| Jun 2007 | - | -$9.76 M(+38.0%) | -$29.63 M(+13.7%) |
| Mar 2007 | - | -$7.08 M(+15.7%) | -$26.06 M(+9.2%) |
| Dec 2006 | -$24.15 M(-20.3%) | -$6.12 M(-8.4%) | -$23.87 M(-7.5%) |
| Sep 2006 | - | -$6.67 M(+7.8%) | -$25.81 M(-1.9%) |
| Jun 2006 | - | -$6.19 M(+26.7%) | -$26.30 M(-2.8%) |
| Mar 2006 | - | -$4.89 M(-39.3%) | -$27.07 M(-8.3%) |
| Dec 2005 | -$30.29 M(+30.8%) | -$8.06 M(+12.4%) | -$29.51 M(-2.2%) |
| Sep 2005 | - | -$7.17 M(+3.0%) | -$30.16 M(+1.7%) |
| Jun 2005 | - | -$6.96 M(-4.9%) | -$29.67 M(+11.1%) |
| Mar 2005 | - | -$7.32 M(-15.9%) | -$26.70 M(+17.2%) |
| Dec 2004 | -$23.16 M(+106.5%) | -$8.71 M(+30.5%) | -$22.79 M(+17.5%) |
| Sep 2004 | - | -$6.68 M(+67.3%) | -$19.39 M(+15.1%) |
| Jun 2004 | - | -$3.99 M(+17.1%) | -$16.85 M(+97.5%) |
| Mar 2004 | - | -$3.41 M(-35.8%) | -$8.53 M(+2.1%) |
| Dec 2003 | -$11.22 M(+627.0%) | -$5.31 M(+28.3%) | -$8.36 M(+36.1%) |
| Sep 2003 | - | -$4.14 M(-195.7%) | -$6.14 M(+2195.4%) |
| Jun 2003 | - | $4.33 M(-233.8%) | -$267.50 K(-88.4%) |
| Mar 2003 | - | -$3.24 M(+4.6%) | -$2.30 M(+61.1%) |
| Dec 2002 | -$1.54 M(-79.5%) | -$3.09 M(-278.4%) | -$1.43 M(-186.0%) |
| Sep 2002 | - | $1.73 M(-24.4%) | $1.66 M(-167.6%) |
| Jun 2002 | - | $2.29 M(-197.0%) | -$2.46 M(-69.3%) |
| Mar 2002 | - | -$2.36 M(-1.1%) | -$8.00 M(-24.0%) |
| Dec 2001 | -$7.53 M(+11.7%) | - | - |
| Aug 2001 | - | -$2.39 M(-26.6%) | -$10.53 M(+8.0%) |
| May 2001 | - | -$3.25 M(+42.9%) | -$9.76 M(+18.4%) |
| Feb 2001 | - | -$2.28 M(-13.0%) | -$8.24 M(+21.3%) |
| Nov 2000 | -$6.74 M(+422.4%) | -$2.62 M(+62.3%) | -$6.79 M(+41.6%) |
| Aug 2000 | - | -$1.61 M(-7.1%) | -$4.80 M(+47.5%) |
| May 2000 | - | -$1.74 M(+109.8%) | -$3.25 M(+69.1%) |
| Feb 2000 | - | -$827.00 K(+33.1%) | -$1.92 M(+48.5%) |
| Nov 1999 | -$1.29 M(-41.7%) | -$621.20 K(+828.6%) | -$1.29 M(+92.3%) |
| Aug 1999 | - | -$66.90 K(-83.6%) | -$672.70 K(+11.0%) |
| May 1999 | - | -$406.90 K(+104.6%) | -$605.80 K(+204.6%) |
| Feb 1999 | - | -$198.90 K | -$198.90 K |
| Nov 1998 | -$2.21 M | - | - |
FAQ
- What is Aurinia Pharmaceuticals annual operating income?
- What is the all time high annual operating profit for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals annual operating profit year-on-year change?
- What is Aurinia Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals quarterly operating profit year-on-year change?
- What is Aurinia Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Aurinia Pharmaceuticals?
- What is Aurinia Pharmaceuticals TTM operating profit year-on-year change?
What is Aurinia Pharmaceuticals annual operating income?
The current annual operating profit of AUPH is -$91.69 M
What is the all time high annual operating profit for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high annual operating income is -$1.29 M
What is Aurinia Pharmaceuticals annual operating profit year-on-year change?
Over the past year, AUPH annual operating income has changed by +$19.78 M (+17.74%)
What is Aurinia Pharmaceuticals quarterly operating income?
The current quarterly operating profit of AUPH is $11.75 M
What is the all time high quarterly operating profit for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high quarterly operating income is $11.75 M
What is Aurinia Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, AUPH quarterly operating income has changed by +$12.19 M (+2763.95%)
What is Aurinia Pharmaceuticals TTM operating income?
The current TTM operating profit of AUPH is -$24.94 M
What is the all time high TTM operating profit for Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals all-time high TTM operating income is $1.66 M
What is Aurinia Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, AUPH TTM operating income has changed by +$28.01 M (+52.90%)